ROS1 Gene Mutation Recruiting Phase 2 Trials for Atezolizumab (DB11595)

IndicationStatusPhase
DBCOND0082893 (ROS1 Gene Mutation)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04042558A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted TherapiesTreatment